Immudyne Retires 1.136 Million Shares - Planning Additional Purchases

Florence, Kentucky. September 29, 2011. Immudyne, Inc. (Pink Sheets: IMMD) a leading industry provider of all-natural products for immune system support from yeast beta-glucan, is pleased to announce the retirement of 1,136,842 shares of the Company’s common stock purchased in a recent private transaction. Mark McLaughlin, CEO of Immudyne stated, “The retiring of these shares is part of ongoing efforts to enhance the value of our long-term shareholders’ ownership in Immudyne. With only 24.5 million shares currently outstanding, and virtually no company debt, our capital structure accommodates future growth both organically and through strategic opportunities.”

2011-09-21 14:01

Immudyne Taps Industry Veteran As Director Of Product Development

Florence, Kentucky, September 21, 2011. Immudyne, Inc. (Pink Sheets: IMMD) the world's leading research and production firm specializing in immune system support compounds based on Beta Glucan derived from baker's yeast, announced today that it has appointed Jim Roufs as Director of Product Development. Mr. Roufs brings more than twenty years of industry experience in the dietary supplement field to augment Immudyne's research and production team. He previously led New Product Development for more than seven years for the world's largest dietary supplement brand, where he participated in developing and launching numerous products with multimillion dollar annual revenues. Mr. Roufs activities will be focused on food and beverage applications for Immudyne's premier Beta Glucan product, as well as dietary supplements for immune system support and athlete training aids.

ImmuDyne Share

Cosmeceutical

Cosmetics are products people use to cleanse or change the look of the face or body.

Products typically labeled as cosmeceuticals include anti-aging creams and moisturizers. Cosmeceuticals are cosmetic products with biologically active ingredients purporting to have medical or drug-like benefits. Dermatological research suggests that the bioactive ingredients used in cosmeceuticals do indeed have benefits beyond the traditional moisturizer.

Cosmetic products that include ingredients designed not only to enhance the appearance but to also have a positive physiological effect at the cellular level. These cosmetic products satisfy both beauty and health needs.

The cosmeceutical market

Actual market evaluations vary and depend largely on the source.

USA

2001: US $ 3 – 10 bn

2007: US $ 5 – 14 bn

2001: US $ 2 – 8 bn

2007: US $ 4 – 10 bn

Skin Care is the second largest cosmetic sector

The main categories for cosmeceuticals are

• Acne treatment: classic target group are teenagers

• Specific skin care: dry skin treatments and skin protection, etc.

• Scar reduction

• Anti-aging

Advantages of liquid UltraPure BetaGlucan (YBG®)

ImmuDyne´s attempts to target this market with a liquid UltraPure YBG®, the advantages can be summarized as follows:

The Langerhans’ cell is an immune-cell
A protective cell residing in the upper layers of the skin (”the control center”)
Protects against both invading microorganisms and against other skin damage
Protects other cells of the skin (immunological effect) and optimizes the local milieu of the skin
Restores normal processes of the skin

Latest News